The calls for a new Bayer CEO have been answered.
Bill Anderson, most recently Roche’s pharmaceutical chief, will become Bayer’s new group CEO starting in June.
Anderson’s installment means Bayer’s current CEO Werner Baumann, who has served the German conglomerate for 35 years, will exit early. Baumann has been Bayer’s helmsman for 7 years and was previously slated to serve in the role through April 2024.
Baumann’s early departure comes amid a fresh wave of investor activism. Several of Bayer’s top shareholders have made their anger with the Bayer CEO public since the Monsanto acquisition in 2018 caused significant losses.